The least glamorous feature on Twentyeight Health’s website may be its most important: a dropdown for insurance. The Brooklyn company will happily tell a cash-paying visitor that Complete Care costs $19.99 a month. But the more revealing price is zero. For members of participating health plans, including Medicaid plans, the membership may cost nothing beyond the ordinary copay, which is often nothing too. In an industry skilled at making a pastel landing page and sending a prescription, Twentyeight has spent years on the dull machinery that determines who can actually use the service.
That machinery now powers something much larger than its original product. The company began with online contraception: complete a short medical intake, let a licensed provider review it, then receive a prescription by mail or at a local pharmacy. Today the menu stretches across emergency contraception, urinary tract infections, bacterial vaginosis, yeast infections, STI treatment, prescription skincare, weight care and prenatal support. Patients can message providers after the transaction. The company is not itself the medical practice - its terms explain that independent licensed provider entities deliver care and third-party pharmacies fill prescriptions - but Twentyeight is the connective tissue.
The customer they chose on purpose
Amy Fan got the founding itch while living in the United States with good employer insurance. Finding an in-network OB-GYN who would accept a new patient still consumed hours. Her private frustration produced a public question: if this system was maddening for someone well insured and able to navigate it, what did it feel like for someone paid hourly, living in a contraceptive desert or enrolled in Medicaid?
Fan had run a direct-to-consumer skincare and makeup business and wanted to import its customer attention into healthcare. Her co-founder, Bruno Van Tuykom, came from Boston Consulting Group and four years of work supporting Gates Foundation programs in family planning, HIV and malaria. They founded Twentyeight in 2018 and launched in 2019. The pairing is almost too tidy: she brought the instinct to make an intimidating service legible; he brought a systems view of access. Both were immigrants - Fan from Canada, Van Tuykom from Belgium - encountering American healthcare with fresh eyes and no sentimental attachment to its paperwork.
“There must be a better way to do this.”Amy Fan, on searching for an in-network OB-GYN
Their first version did one job. A patient could spend about five minutes on an online medical questionnaire, consult a provider and, when clinically appropriate, receive birth control. More than 100 brands now sit behind that simple path, including pills, patches, rings, shots and emergency contraception. This breadth matters. The company is not merely pushing a private-label pill; it is organizing access to options.
The product is a relay race
A patient does not wake up wanting “telehealth.” She wants an answer before the next refill, a treatment without a waiting room, or contraception without explaining her life to a new office receptionist. Twentyeight’s service is best understood as a relay: collect the right clinical information, route it to an appropriately licensed provider, send the prescription to a pharmacy, apply insurance when possible and keep a channel open for questions or adjustments.
One need, four handoffs
Complete Care, launched in 2026, packages those handoffs into one membership. Out-of-pocket pricing starts at $19.99 monthly, with discounts for quarterly or annual payment. Medication costs are separate and can begin around $16 a month for cash-pay customers. In-network members may get the membership for $0; care and drugs are then billed through insurance and remain subject to a copay. Most services can be handled asynchronously, while some insurance plans and state rules require a short video visit.
This hybrid model is the company’s answer to a nasty digital-health tension. Cash payment is clean and quick but excludes the people most sensitive to cost. Insurance expands access but adds credentialing, claims, eligibility checks and plan-by-plan variation. Twentyeight does both. It also finds patients through Medicaid insurers, nonprofits, colleges, community groups and, lately, consumer-health products. Each route can lower dependence on buying the same expensive social-media click as every other telehealth brand.
What failed first was the easy version
The cautionary part of this story belongs to the category. SimpleHealth wound down in April 2023. Twentyeight became custodian of its patient records and continued care where it could operate. The company also acquired a portion of The Pill Club’s patient assets after that rival collapsed. These transfers helped Twentyeight pass 100,000 users by October 2024, but they were not tidy customer-list purchases. Patients arrived with prescriptions, delivery schedules, insurance histories and expectations set by another brand.
Public customer complaints show what breaks first in such transitions: billing clarity, refill timing and support. Some former users objected when pricing or plans changed. A healthcare migration can look like cheap acquisition on a spreadsheet and feel like an ambush to the person whose card is charged or prescription is late. Twentyeight’s broader lesson is uncomfortable but copyable: continuity is part of the product. A company buying patient relationships must budget for communication and service recovery, not only record transfer.
The strategy does not work everywhere at once. Provider licensing, prescribing rules, insurer contracts and pharmacy coverage vary by state. A $0 membership in one plan can be $19.99 plus medication in another. Without reimbursement expertise and enough clinical capacity, serving cost-sensitive patients becomes a promise the operating model cannot keep.
The change of mind: from wedge to clinic
Twentyeight did not abandon contraception. It reclassified it as the front door. The shift was visible by 2022, when Fan described an ambition to support patients from puberty to menopause. It became concrete with services for infections, skin and weight, then explicit with Complete Care. The logic is simple: a company that already knows a patient, her insurance and her preferred pharmacy has an advantage when the next common health need appears.
The company raised $5.1 million in 2020, $8.3 million in 2023 and a $10 million Series A announced in January 2025. The Series A, led by Seae Ventures, arrived with new payer relationships involving Aetna, AmeriHealth Caritas and Molina Healthcare. This pairing matters more than the round’s letter. Venture money financed expansion, but insurer contracts made the service plausibly affordable at scale.
By April 2026, Twentyeight said it worked with more than 100 insurance partners whose plans covered roughly 16 million women. “Covered” is reach, not the same as active patients, but it shows the distribution surface. The next month, a partnership with Oura created another entrance: eligible U.S. members can bring sleep, cycle and symptom data into contraceptive counseling with a Twentyeight provider. A later Clue partnership linked cycle tracking to birth-control care. Oura has signals; Clue has attention; Twentyeight has clinicians and fulfillment. The handoff is the product.
The thing worth stealing
Founders can copy the sequence without copying the clinic. Start with one recurring problem whose successful resolution creates permission to solve the next one. Build the boring rails early. Choose distribution partners already trusted by the customer. Make price architecture visible. Then expand only into adjacent services that reuse the same identity, payment, professional and fulfillment infrastructure.
There is also a sharper strategic choice here: Twentyeight aimed at people its digital-first competitors had weak incentives to serve. Medicaid is administratively difficult, margins can be tighter and coverage differs by jurisdiction. Yet the very difficulty can produce defensibility. Competitors include Nurx, Wisp, Hers, Planned Parenthood Direct and local practices. Several offer overlapping conditions and prettier versions of convenience. Fewer combine Medicaid participation, community partnerships, ongoing messaging and a multi-condition membership.
The model still has limits. Telehealth cannot replace an examination, procedure, lab or emergency service. A provider may decide a prescription is inappropriate. A service available in New York may not be offered in another state. Insurance can turn a zero-dollar promise into a confusing copay. And widening from reproductive care into skincare and weight care risks making a distinct mission feel like a generic catalogue.
Twentyeight’s answer is to keep the mission as the organizing constraint: affordable, judgment-free care for communities the system underserves. Its site says the team includes clinicians, public-health experts, designers, engineers and builders; it welcomes different gender identities, sexualities and pronouns; and it donates 1 percent of revenue to the National Institute for Reproductive Health. Those are values. The operating proof is whether the next patient gets an answer, understands the bill and receives the medication on time.
The website sells convenience. The company is really selling a completed handoff.The advantage is not the questionnaire - it is everything that happens next.
That is what makes Twentyeight interesting in a crowded market. It did not invent online prescribing or discreet packaging. It assembled a care path around a deliberate customer, survived the operational burden of inherited patients, and turned insurance acceptance from a checkout option into strategy. The five-minute intake was the wedge. The harder, more valuable work begins at minute six.